Review
doi: 10.1159/000116476.
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies
Affiliations
- PMID: 2693102
- DOI: 10.1159/000116476
Item in Clipboard
Review
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies
Eur Neurol.
1989.
Abstract
Alzheimer's disease (AD) is becoming an increasingly important public health problem. The clinical diagnosis of AD continues to be problematic and costly. [18F]-fluorodeoxyglucose-position emission tomography (FDG-PET) can assist with the diagnosis of AD at an early stage. The utility of FDG-PET in AD may also be extremely useful in the future when objective physiologic monitoring of drug effects and therapy are required.
Similar articles
-
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.J Comput Assist Tomogr. 1983 Aug;7(4):590-8. doi: 10.1097/00004728-198308000-00003. J Comput Assist Tomogr. 1983. PMID: 6602819
-
Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia.Eur Neurol. 1989;29 Suppl 3:9-15. doi: 10.1159/000116474. Eur Neurol. 1989. PMID: 2612532
-
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86. doi: 10.1002/gps.4102. Epub 2014 Mar 29. Int J Geriatr Psychiatry. 2014. PMID: 24687634
-
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510. doi: 10.1007/s00259-005-1762-7. Eur J Nucl Med Mol Imaging. 2005. PMID: 15747152 Review.
-
Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S29-36. doi: 10.1016/j.jalz.2007.10.004. Epub 2007 Dec 21. Alzheimers Dement. 2008. PMID: 18631997 Review.
Cited by
-
Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology.Mol Imaging Biol. 2006 May-Jun;8(3):151-62. doi: 10.1007/s11307-006-0037-4. Mol Imaging Biol. 2006. PMID: 16552500
-
Assessment of functional development in normal infant brain using arterial spin labeled perfusion MRI.Neuroimage. 2008 Feb 1;39(3):973-8. doi: 10.1016/j.neuroimage.2007.09.045. Epub 2007 Oct 5. Neuroimage. 2008. PMID: 17988892 Free PMC article.
-
Association of hypometabolism and amyloid levels in aging, normal subjects.Neurology. 2014 Jun 3;82(22):1959-67. doi: 10.1212/WNL.0000000000000467. Epub 2014 May 2. Neurology. 2014. PMID: 24793183 Free PMC article.
-
Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus.J Neurol Neurosurg Psychiatry. 1995 Dec;59(6):608-15. doi: 10.1136/jnnp.59.6.608. J Neurol Neurosurg Psychiatry. 1995. PMID: 7500099 Free PMC article.
-
Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.Curr Neuropharmacol. 2011 Dec;9(4):693-705. doi: 10.2174/157015911798376334. Curr Neuropharmacol. 2011. PMID: 22654727 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
